Skip to main content
Year archive

Viva Biotech Holdings — 2020 filings

All 83 regulatory filings released by Viva Biotech Holdings (1873) in 2020, sourced directly from the official regulator.

83 Filings
2020 Period
2020 filings (83)
Filing Released Lang
PUBLICATION OF THE OFFERING CIRCULAR- VIVA BIOTECH INVESTMENT MANAGEMENT LIMITED - US$280 million 1.00% Guaranteed Convertible Bonds due 2025
Report Publication Announcement
2020-12-31 English
NOTICE OF ISSUE AND LISTING ON THE STOCK EXCHANGE OF HONG KONG LIMITED - VIVA BIOTECH INVESTMENT MANAGEMENT LIMITED - US$280 million 1.00% Guaranteed Convertible Bonds due 2025
Capital/Financing Update
2020-12-30 English
COMPLETION OF THE ISSUE OF US$280 MILLION 1.00 PER CENT GUARANTEED CONVERTIBLE BONDS DUE 2025
Capital/Financing Update
2020-12-30 English
MAJOR TRANSACTION UPDATE ON POTENTIAL ISSUE OF CONSIDERATION SHARES
Capital/Financing Update
2020-12-23 English
PROPOSED ISSUE OF US$280 MILLION 1.00% GUARANTEED CONVERTIBLE BONDS DUE 2025
Capital/Financing Update
2020-12-18 English
MAJOR TRANSACTION FURTHER DELAY IN DISPATCH OF CIRCULAR, APPLICATION FOR A WAIVER UNDER RULE 14.41(A) OF THE LISTING RULES AND EXTENSION OF THE LONGSTOP DATE
Capital/Financing Update
2020-12-15 English
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 30 November 2020
Share Issue/Capital Change
2020-12-04 English
COMPLETION OF VERY SUBSTANTIAL ACQUISITION IN RELATION TO 80% OF THE EQUITY INTEREST OF LANGHUA PHARMACEUTICAL
M&A Activity
2020-11-13 English
POLL RESULTS OF THE EXTRAORDINARY GENERAL MEETING HELD ON NOVEMBER 9, 2020
Declaration of Voting Results & Voting Rights Announcements
2020-11-09 English
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 31 October 2020
Capital/Financing Update
2020-11-05 English
LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION
Board/Management Information
2020-11-03 English
RESIGNATION OF NON-EXECUTIVE DIRECTOR
Board/Management Information
2020-11-03 English
POLL RESULTS OF THE EXTRAORDINARY GENERAL MEETING HELD ON OCTOBER 21, 2020
Declaration of Voting Results & Voting Rights Announcements
2020-10-21 English
FORM OF PROXY FOR USE AT SECOND EXTRAORDINARY GENERAL MEETING
Proxy Solicitation & Information Statement
2020-10-16 English
NOTICE OF THE EXTRAORDINARY GENERAL MEETING
Proxy Solicitation & Information Statement
2020-10-16 English
(1) VERY SUBSTANTIAL ACQUISITION IN RELATION TO 80% OF THE EQUITY INTEREST OF LANGHUA PHARMACEUTICAL&#x3b; AND (2) NOTICE OF SECOND EXTRAORDINARY GENERAL MEETING IN 2020
Proxy Solicitation & Information Statement
2020-10-16 English
MAJOR TRANSACTION GRANT OF WAIVER FROM STRICT COMPLIANCE WITH RULE 14.41(A) OF THE LISTING RULES AND DELAY IN DISPATCH OF CIRCULAR
Regulatory Filings
2020-10-15 English
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 30 September 2020
Share Issue/Capital Change
2020-10-06 English
FURTHER DELAY IN DISPATCH OF CIRCULAR IN RELATION TO VERY SUBSTANTIAL ACQUISITION
Regulatory Filings
2020-09-29 English
Interim Report 2020
Regulatory Filings
2020-09-28 English
PROPOSED INCREASE OF AUTHORIZED SHARE CAPITAL AND NOTICE OF FIRST EXTRAORDINARY GENERAL MEETING IN 2020
Proxy Solicitation & Information Statement
2020-09-25 English
FORM OF PROXY FOR USE AT EXTRAORDINARY GENERAL MEETING
Proxy Solicitation & Information Statement
2020-09-25 English
NOTICE OF THE EXTRAORDINARY GENERAL MEETING
Share Issue/Capital Change
2020-09-25 English
PROPOSED INCREASE OF AUTHORIZED SHARE CAPITAL
Share Issue/Capital Change
2020-09-23 English
DISCLOSEABLE TRANSACTION-ENTRY INTO THE INVESTMENT AGREEMENT WITH HANGZHOU QIANTANG NEW AREA MANAGEMENT COMMITTEE
Capital/Financing Update
2020-09-22 English
MAJOR TRANSACTION ACQUISITION OF THE ENTIRE EQUITY INTEREST IN SYNTHESIS MED CHEM (HONG KONG) LIMITED
M&A Activity
2020-09-21 English
DELAY IN DISPATCH OF CIRCULAR IN RELATION TO VERY SUBSTANTIAL ACQUISITION
Regulatory Filings
2020-09-11 English
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 31 August 2020
Capital/Financing Update
2020-09-04 English
(Revised) Monthly Return of Equity Issuer on Movements in Securities for the Month ended 31 July 2020
Capital/Financing Update
2020-09-04 English
(Revised) Monthly Return of Equity Issuer on Movements in Securities for the Month ended 30 June 2020
Regulatory Filings
2020-09-04 English
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2020
Interim / Quarterly Report
2020-08-31 English
DATE OF BOARD MEETING
Regulatory Filings
2020-08-19 English
PROFIT WARNING
Regulatory Filings
2020-08-16 English
VERY SUBSTANTIAL ACQUISITION IN RELATION TO 80% OF THE EQUITY INTEREST OF LANGHUA PHARMACEUTICAL
M&A Activity
2020-08-09 English
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 31 July 2020
Capital/Financing Update
2020-08-06 English
2019 ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT
Environmental & Social Information
2020-07-16 English
Next Day Disclosure Return
Share Issue/Capital Change
2020-07-13 English
COMPLETION OF PLACING OF NEW SHARES UNDER GENERAL MANDATE
Capital/Financing Update
2020-07-10 English
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 30 June 2020
Share Issue/Capital Change
2020-07-07 English
(Revised) Monthly Return of Equity Issuer on Movements in Securities for the Month ended 31 May 2020
Regulatory Filings
2020-07-07 English
(Re-published for debt holders information) PLACING OF NEW SHARES UNDER GENERAL MANDATE AND RESUMPTION OF TRADING
Capital/Financing Update
2020-07-03 English
PLACING OF NEW SHARES UNDER GENERAL MANDATE AND RESUMPTION OF TRADING
Capital/Financing Update
2020-07-03 English
EXCHANGE NOTICE - RESUMPTION OF TRADING
Regulatory Filings
2020-07-03 English
PLACING OF NEW SHARES UNDER GENERAL MANDATE AND RESUMPTION OF TRADING
Capital/Financing Update
2020-07-03 English
TRADING HALT
Regulatory Filings
2020-07-03 English
EXCHANGE NOTICE - TRADING HALT
Regulatory Filings
2020-07-03 English
DISCLOSEABLE TRANSACTION-SUCCESSFUL BIDDING OF LAND USE RIGHT FOR A PROPERTY IN SHANGHAI
Capital/Financing Update
2020-07-01 English
Next Day Disclosure Return
Capital/Financing Update
2020-06-16 English
POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON JUNE 10, 2020 AND CHANGE OF AUDITOR
Declaration of Voting Results & Voting Rights Announcements
2020-06-10 English
ADOPTION OF RESTRICTED SHARE UNIT SCHEME
Capital/Financing Update
2020-06-05 English
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 31 May 2020
Regulatory Filings
2020-06-03 English
GRANT OF SHARE OPTIONS
Share Issue/Capital Change
2020-05-21 English
INSIDE INFORMATION THE POTENTIAL ACQUISITION OF 60% OF THE EQUITY INTEREST OF LANGHUA PHARMACEUTICAL AND UPDATE ON POTENTIAL STRATEGIC INVESTMENT AND COOPERATION
M&A Activity
2020-05-20 English
DISCLOSEABLE TRANSACTION-ENTRY INTO CONSTRUCTION CONTRACT
Capital/Financing Update
2020-05-11 English
FORM OF PROXY FOR USE AT ANNUAL GENERAL MEETING
Proxy Solicitation & Information Statement
2020-05-08 English
NOTICE OF ANNUAL GENERAL MEETING
AGM Information
2020-05-08 English
PROPOSED RE-ELECTION OF RETIRING DIRECTORS PROPOSALS FOR GRANTING OF GENERAL MANDATES TO ISSUE SHARES AND REPURCHASE SHARES PROPOSED DECLARATION AND PAYMENT OF FINAL DIVIDEND PROPOSED APPOINTMENT OF N
AGM Information
2020-05-08 English
PROPOSED CHANGE OF AUDITOR
Regulatory Filings
2020-05-07 English
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 30 April 2020
Major Shareholding Notification
2020-05-06 English
Next Day Disclosure Return
Share Issue/Capital Change
2020-05-05 English
2019 Annual Report
Regulatory Filings
2020-04-28 English
Next Day Disclosure Return
Share Issue/Capital Change
2020-04-06 English
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 31 March 2020
Regulatory Filings
2020-04-03 English
Next Day Disclosure Return
Share Issue/Capital Change
2020-04-01 English
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2019
Annual Report
2020-03-30 English
INSIDE INFORMATION AMENDMENT OF DIVIDEND POLICY
Regulatory Filings
2020-03-30 English
LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION
Board/Management Information
2020-03-30 English
RESIGNATION OF NON-EXECUTIVE DIRECTOR AND APPOINTMENT OF NON-EXECUTIVE DIRECTOR
Board/Management Information
2020-03-30 English
DATE OF BOARD MEETING
Regulatory Filings
2020-03-18 English
POSITIVE PROFIT ALERT
Earnings Release
2020-03-16 English
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 29 February 2020
Capital/Financing Update
2020-03-04 English
COMPLETION OF THE ISSUE OF US$180 MILLION 2.50 PER CENT GUARANTEED CONVERTIBLE BONDS DUE 2025
Capital/Financing Update
2020-02-11 English
VIVA INCUBATOR INVESTMENT MANAGEMENT LIMITED-US$180 MILLION 2.50% GUARANTEED CONVERTIBLE BONDS DUE 2025
Capital/Financing Update
2020-02-11 English
SUPPLEMENTAL ANNOUNCEMENT PROPOSED ISSUE OF US$180 MILLION GUARANTEED CONVERTIBLE BONDS DUE 2025
Capital/Financing Update
2020-02-05 English
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 31 January 2020
Share Issue/Capital Change
2020-02-05 English
Next Day Disclosure Return
Transaction in Own Shares
2020-01-30 English
PROPOSED ISSUE OF USD-DENOMINATED GUARANTEED CONVERTIBLE BONDS
Capital/Financing Update
2020-01-23 English
PROPOSED ISSUE OF US$180 MILLION GUARANTEED CONVERTIBLE BONDS DUE 2025
Capital/Financing Update
2020-01-23 English
PROPOSED ISSUE OF US$180 MILLION GUARANTEED CONVERTIBLE BONDS DUE 2025
Capital/Financing Update
2020-01-22 English
PROPOSED ISSUE OF USD-DENOMINATED GUARANTEED CONVERTIBLE BONDS
Capital/Financing Update
2020-01-22 English
DISCLOSEABLE TRANSACTION IN RELATION TO ACQUISITION OF 100% EQUITY INTEREST IN A PRC COMPANY HOLDING PROPERTY IN SHANGHAI
Capital/Financing Update
2020-01-21 English
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 31 December 2019
Share Issue/Capital Change
2020-01-03 English
VOLUNTARY ANNOUNCEMENT-DISPOSAL OF SHARES IN PORTFOLIO INCUBATOR COMPANY
Capital/Financing Update
2020-01-02 English